Due to the central role of AR in all phases of prostate cancer, modulating AR protein stability or AR cofactor activity represents an effective strategy to overcome most of the mechanisms of resistance and may have therapeutic implications in this disease. This evidence concerns the gene AR and Familial prostate cancer.